Oncternal Therapeutics, Inc.
ONCT · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $37 | $91 | $117 |
| Short-Term Investments | $28 | $27 | $0 | $0 |
| Receivables | $1 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $3 | $2 | $1 |
| Total Curr. Assets | $36 | $67 | $93 | $118 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $1 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37 | $69 | $94 | $119 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $2 |
| Other Curr. Liab. | $4 | $5 | $3 | $3 |
| Total Curr. Liab. | $5 | $8 | $5 | $6 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $3 | $0 | $0 |
| Other Liabilities | $0 | -$3 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $8 | $5 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$198 | -$158 | -$114 | -$83 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $228 | $219 | $202 | $196 |
| Total Equity | $30 | -$158 | -$114 | -$83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $37 | $69 | -$109 | -$77 |
| Net Debt | -$6 | -$37 | -$91 | -$117 |